These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3120520)

  • 1. [The intraocular penetration of ARI (M-79175) in rabbit eyes].
    Kojima M; Sasaki K; Taniguchi T
    Nippon Ganka Gakkai Zasshi; 1987 Jun; 91(6):643-6. PubMed ID: 3120520
    [No Abstract]   [Full Text] [Related]  

  • 2. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1669-73. PubMed ID: 2950739
    [No Abstract]   [Full Text] [Related]  

  • 4. Corneal permeability of aldose reductase inhibitor, M79175. I. In vitro study using corneal permeability apparatus.
    Kato A; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):279-86. PubMed ID: 3139808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N; Sakamoto N
    Nihon Rinsho; 1987 Dec; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 7. Corneal permeability of aldose reductase inhibitor, M79175. II. In vivo study on pharmacokinetic aspect.
    Kato A; Horie T; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):287-94. PubMed ID: 3139809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase inhibition for diabetic neuropathy.
    Lancet; 1983 Oct; 2(8356):969. PubMed ID: 6138528
    [No Abstract]   [Full Text] [Related]  

  • 9. High-performance liquid chromatographic analysis of glucose, fructose, sorbitol and low levels of the aldose reductase inhibitor sorbinil in human lens and plasma.
    Lloyd P; Crabbe MJ
    J Chromatogr; 1985 Oct; 343(2):402-6. PubMed ID: 3934205
    [No Abstract]   [Full Text] [Related]  

  • 10. The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
    Crabbe MJ; Petchey M; Burgess SE; Cheng H
    Exp Eye Res; 1985 Jan; 40(1):95-9. PubMed ID: 3920064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sorbinil on the pathophysiology of diabetic complications. Proceedings of a symposium. Dorado, Puerto Rico, May 30-June 2, 1985.
    Metabolism; 1986 Apr; 35(4 Suppl 1):1-121. PubMed ID: 3083196
    [No Abstract]   [Full Text] [Related]  

  • 12. Sorbinil and limited joint mobility in diabetics.
    JAMA; 1985 Sep; 254(11):1452-4. PubMed ID: 3928912
    [No Abstract]   [Full Text] [Related]  

  • 13. Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.
    Ohashi Y; Awata T; Sogo S; Ohira M; Matsuda M; Fukuda M; Manabe R
    J Ocul Pharmacol; 1989; 5(4):325-8. PubMed ID: 2516866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y; Takahashi Y; Tanabe T; Ikebe H; Majima K; Miyatani H; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of pericyte ghost formation in retinal capillaries by aldose reductase inhibitor in galactose-fed dogs with diabetic retinopathy].
    Akagi Y; Terubayashi H; Ikebe H; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Sep; 92(9):1479-84. PubMed ID: 3145681
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 19. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 20. Early retinal microangiopathy: prevention with aldose reductase inhibitors.
    Robison WG; Kador PF; Kinoshita JH
    Diabet Med; 1985 May; 2(3):196-9. PubMed ID: 2952420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.